🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2018-11-20
Trial ID
NCT03751202
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2020-09-22
Trial ID
NCT04564456
This is a randomized, multi-center, active-controlled, repeated measures de...
Status
Completed
Location
3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa
Start Date
2016-04
Trial ID
NCT02757209
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02238106
The objective of this study is to investigate if the systemic drug exposure...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02254187
Treatments Being Tested
Asthma is a common, serious illness among children in the United States. Wh...
Status
Completed
Location
University of Arizona College of Medicine
Start Date
2007-03
Trial ID
NCT00395304
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Unknown
Location
BECRO Clinical Facility
Start Date
2021-01-18
Trial ID
NCT04746040
This study evaluates the effect of two medicines on COPD (Chronic Obstructi...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-12
Trial ID
NCT00115492
Treatments Being Tested